Other investigations on human pancreatic cancer cell lines PANC-1 and BxPC-3 showed that treatment with TRAIL reduced the expression of DR4 and pointedly improved DCR1/2 expression, leading to inhibition of TRAIL-induced apoptosis, while OPG levels persisted unaffected. Here, TNFSF10 is linked to pancreatic neoplasm.